Company Monitoring Page for Astellas

latest headlines for company on cafepharma

CHMP Recommends Astellas Pharma Europe Ltd.'s (APEL) DIFICLIR for Approval in the EU
Yahoo/PR NewsWire
Sat, 09/24/11 - 12:40 pm
Tags:
Optimer Pharmaceuticals, Astellas, Dificlir, Clostridium Difficile, fidaxomicin
Astellas clot drug raises bleeding in heart study
Reuters
Tue, 08/30/11 - 09:44 am
Tags:
Astellas, anticoagulants, Darexaban
Switching Partners Provides a Big Shot in the Arm
Motley Fool
Wed, 07/27/11 - 10:54 pm
Tags:
Merck, Cardiome, Astellas, Pfizer, Bristol-Myers Squibb, JNJ
Merck snags Astellas' U.S. rights to IV vernakalant
Fierce Biotech
Wed, 07/27/11 - 02:39 pm
Tags:
Vernakalant, Merck, Astellas, atrial fibrillation
Astellas eyes cancer drugs to stabilize profit picture
Fierce Pharma
Wed, 07/20/11 - 01:05 pm
Tags:
Astellas, cancer
Vical jumps 7% on vaccine deal
Marketwatch
Fri, 07/15/11 - 02:38 pm
Tags:
Vical, Astellas, vaccines, TransVax, CMV
Vical inks licensing deal with Astellas over vaccine for stem-cell transplant patients
Yahoo/AP
Fri, 07/15/11 - 01:07 am
Tags:
Vical, licensing, Astellas, vaccines, stem cell transplant
Astellas to Sell Pfizer’s Caduet Drug in Japan From October
Bloomberg
Fri, 07/8/11 - 11:59 am
Tags:
Astellas, Pfizer, Caduet, Japan
Astellas' patent sale gins $609M for new round of dealmaking
Fierce Biotech
Thu, 06/30/11 - 09:36 am
Tags:
Astellas, patents, diabetes, OSI Pharmaceuticals
Seattle Genetics and Astellas start development of second experimental cancer drug
Yahoo/AP
Thu, 06/9/11 - 08:02 am
Tags:
Seattle Genetics, Astellas, cancer
Medivation and Astellas Announce New Study Results Confirming Clinical Effects and Tolerability of MDV3100 in Advanced Prostate Cancer
Yahoo/MarketWire
Sat, 06/4/11 - 10:01 am
Tags:
Medivation, Astellas, MDV3100, prostate cancer
5 Biotechs With Upcoming Clinical Trial Results
Motley Fool
Wed, 06/1/11 - 07:52 am
Tags:
Amarin, AMR101, cabozantinib, Exelixis, HIV quad pill, Gilead Sciences, Medivation, MDV3100, Astellas, Vical, skin cancer, YM BioSciences, nimotuzumab
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Fierce Biotech
Thu, 05/19/11 - 02:08 pm
Tags:
abiraterone, prostate cancer, Medivation, MDV3100, dimebon, Pfizer, Astellas
MDV3100 in New Phase II Study
Yahoo/Zacks
Sat, 05/14/11 - 12:52 pm
Tags:
Medivation, MDV3100, prostate cancer, Casodex, AstraZeneca, Astellas
Comparing Medivation, Inc.'s and Johnson & Johnson's Prostate Cancer Drugs
Seeking Alpha
Mon, 03/21/11 - 02:56 pm
Tags:
prostate cancer, Medivation, JNJ, Pfizer, Astellas, MDV3100, abiraterone
Astellas, Partners Reach Settlement With Teva on Tarceva Patent
Bloomberg
Wed, 03/16/11 - 09:17 am
Tags:
Astellas, Teva Pharmaceuticals, Tarceva, patents
Astellas, AVEO Pharma enter worldwide pact to develop & commercialize tivozanib outside of Asia
Pharmabiz
Sat, 02/19/11 - 12:07 pm
Tags:
Astellas, Aveo Pharmaceutical
Aveo Pharma, Astellas in $1.3B cancer drug deal
Yahoo/AP
Thu, 02/17/11 - 09:01 am
Tags:
Aveo Pharmaceutical, Astellas, cancer, tivozanib, Pfizer, ONYX Pharmaceuticals
Optimer lands $224M licensing pact for promising antibiotic
Fierce Biotech
Mon, 02/7/11 - 11:33 am
Tags:
antibiotics, Optimer, fidaxomicin, Astellas
Roche’s Tarceva Extends Lives, Study Stopped Early
Bloomberg
Fri, 01/28/11 - 09:41 am
Tags:
Astellas, Tarceva, lung cancer, Roche

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.